SAN ANTONIO -- Patients with asthma at one large academic medical center were not prescribed a biologic therapy very often over a 5-year period, a researcher reported, although patient adherence to a ...

Biologic drugs for asthma may be initiated or continued while conceiving or during pregnancy or breastfeeding following appropriate risk-benefit discussions and shared decision-making, a consensus ...

The research, conducted in Germany, found that biologic treatment for asthma resulted in reduced health care resource utilization (HCRU), as seen in fewer hospitalizations and oral corticosteroid ...

Going from a medium-dose inhaled corticosteroid to a biologic for asthma led to significant decreases in exacerbations, ...

Uncrowned is a new destination for all things MMA, boxing, wrestling, and more, featuring Ariel Helwani. Yahoo Racing is powered by Motorsport Network, providing expert reporting, analysis, and ...

Results showed annualized asthma exacerbation rates were reduced in all age groups 6 months after compared with 6 months before initiating a biologic. Among patients with severe asthma, treatment with ...

Most patients with severe asthma who were treated with the biologic therapy benralizumab were able to reduce their dose of inhaled corticosteroid (ICS), and more than half could stop steroid use ...

Please provide your email address to receive an email when new articles are posted on . ANAHEIM, Calif. — “There are a lot of interesting trends,” John J. Oppenheimer, MD, FACAAI, clinical professor ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved depemokimab (Exdensur, GSK plc) as add-on therapy for severe asthma and for chronic rhinosinusitis with nasal polyps (CRSwNP ...

Dupilumab (interleukin-4Rα; antibody binds to interleukin-4Rα, inhibiting interleukin-4 and interleukin-13 signaling in hematopoietic cells [e.g., B cells, CD4+ helper T cells, and eosinophils], ...

Biologic treatment demonstrated a significantly lower risk of pneumonia vs non-biologic treatment (HR, 0.91 [95% CI, 0.85-0.98]; P =.013). Asthma biologic use was not associated with an increased risk ...

Asthma causes inflammation and narrowing of the airways, making it harder to breathe. Symptoms may include wheezing, coughing, chest tightness, and shortness of breath. These symptoms can vary in ...